BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Hemispherx Biopharma Inc. 

One Penn Center
1617 JFK Boulevard
Philadelphia  Pennsylvania  19103  U.S.A.
Phone: 215-988-0080 Fax: 215-988-1739


SEARCH JOBS








 Company News
Hemispherx Biopharma (HEB) Announces New Publication Enlarges The Understanding Of Ampligen® Safety Profile Across Diverse Animal Species And Focuses On The Unique TLR-3 Receptor/Ampligen(R) Interaction 4/8/2014 7:31:48 AM    More...
Hemispherx Biopharma (HEB) Presented Clinical Interpretations On CFS Treatment At The 11th Biennial International Research And Clinical Conference 3/24/2014 8:52:31 AM    More...
Hemispherx Biopharma (HEB) To Present Clinical Interpretations On CFS Treatment At The 11th Biennial International Research And Clinical Conference 3/19/2014 9:48:33 AM    More...
Hemispherx Biopharma (HEB) Announces Plans To File For Regulatory Approval Of Ampligen® To Treat Chronic Fatigue Syndrome (CFS) In Three Additional Latin America Countries 3/11/2014 9:20:31 AM    More...
Hemispherx Biopharma (HEB) Wins Federal Lawsuit Regarding Investment Banking Fees 3/10/2014 9:51:04 AM    More...
Hemispherx Biopharma (HEB) Publishes Full National Press Club Presentation On Corporate Website 2/24/2014 8:47:27 AM    More...
Hemispherx Biopharma (HEB) Summarizes Clinical Results Presented In Washington, DC On January 30, 2014 In Conjunction With The American Society for Microbiology Biodefense Conference Aimed At Developing A Universal Influenza Vaccine To Prevent Pandemic Influenza Threat 2/4/2014 9:04:51 AM    More...
Hemispherx Biopharma (HEB) Release: A Clinical Update On The Search For A Universal Flu Vaccine: Presentation In Washington, DC On January 30, 2014 In Conjunction With The American Society of Microbiology Biodefense Conference 1/28/2014 9:08:19 AM    More...
Hemispherx Biopharma (HEB) And Researchers With The University of Alabama at Birmingham To Discuss Clinical Trial Studies Aimed At Developing A Universal Influenza Vaccine To Prevent Pandemic Influenza Threat 1/27/2014 10:42:54 AM    More...
Hemispherx Biopharma (HEB) Analysis Of New Data On Protection From Pulmonary Damage Associated With Infection By Highly Pathogenic Influenza Virus 1/22/2014 8:50:30 AM    More...
12345678910...

//-->